3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
3
Breast Neoplasms
3
Papillomavirus Infections
2
Melanoma
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Sarcoma
1
Prostatic Neoplasms
1
Neuroblastoma
1
Neoplasms, Nerve Tissue
1
NY-ESO-1-expressing Tumors
1
Leukemia, Myeloid, Acute
1
Herpes Zoster
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Condylomata Acuminata
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Anus Neoplasms
1
Adenoviridae Infections
1
Adenocarcinoma
1
Interventions
Carboplatin
9
pembrolizumab
8
Paclitaxel
8
Cisplatin
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Gemcitabine
5
fludarabine
4
Specimen Handling
4
Pemetrexed
4
Nivolumab
4
Cyclophosphamide
4
trebananib
3
osimertinib
3
liposomal doxorubicin
3
Radiotherapy
3
Interleukin-2
3
Fluorouracil
3
Docetaxel
3
DNA
3
volociximab
2
poly ICLC
2
lenvatinib
2
fludarabine phosphate
2
Sorafenib
2
Radiosurgery
2
Midazolam
2
Capecitabine
2
Biopsy
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma
×
Vaccines
×
Clear all
NCT00684294
2020-03-02
Auto TAG
Mary Crowley Medical Research Center
Phase 1
Terminated
46 enrolled